Congruence Therapeutics
Develops small molecule correctors for diseases of protein misfolding
$39.5MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops small molecule correctors for diseases of protein misfolding
Develops therapies to halt fibrosis in multiple organ systems